Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00802854

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:05.407342+00:00

Published At

2017-11-30T00:00:00+00:00

Record Updated At

2018-11-21

Results Posted At

2017-11-30

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Candidemia", "Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-11-21"

protocolSection.identificationModule.nctId

"NCT00802854"

protocolSection.identificationModule.officialTitle

"Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-11-30"

Study condition terms

• Candidemia (protocolSection.conditionsModule.conditions)
• Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.